23 April 2026: Articles
Bacteremia and Liver Failure Due to Non-K1 Escherichia coli With iss Gene in Two Full-Term Infants
Challenging differential diagnosis, Diagnostic / therapeutic accidents, Management of emergency care, Rare coexistence of disease or pathology
Yuuki Shikaze ABCDEF 1, Shinsuke MizunoDOI: 10.12659/AJCR.949819
Am J Case Rep 2026; 27:e949819
Abstract
BACKGROUND: Escherichia coli is a major pathogen causing sepsis in neonates and young infants. Although the K1 capsule is a well-established virulence factor in invasive infections, the clinical relevance of non-K1 strains and alternative virulence factors remains insufficiently characterized, particularly in cases of pediatric liver failure. The increased serum survival (iss) gene confers resistance to complement-mediated killing; however, its clinical relevance in infants has not been clarified.
CASE REPORT: Two full-term infants developed acute liver failure complicated by septic shock within the first month of life. Blood cultures in both cases yielded non-K1 E. coli strains harboring the iss gene. Both patients required intensive care, including plasma exchange and continuous renal replacement therapy; they ultimately underwent liver transplantation. Detailed microbiological and molecular analyses confirmed the absence of the K1 capsule and identified iss-associated virulence profiles across distinct phylogenetic backgrounds, suggesting a shared mechanism of serum resistance distinct from classical neonatal-meningitis-associated pathogenicity.
CONCLUSIONS: These cases underscore an important clinical insight: acute liver failure in infants can unmask invasive infection, even when classical virulence markers such as the K1 capsule are absent. Host-related impairment of complement production and innate immunity may reveal the pathogenic potential of iss-positive non-K1 strains. Awareness of such host-pathogen interactions may improve diagnostic evaluation and risk stratification in this vulnerable population.
Keywords: Bacteremia, Complement Activation, Escherichia coli, Liver failure, Virulence Factors
Introduction
MICROBIOLOGICAL AND MOLECULAR DIAGNOSTIC INFORMATION:
Bacterial strains were isolated from clinical samples in the bacteriological laboratory and sent to the Kagoshima University Graduate School of Medical and Dental Sciences for further analysis. O serogroups were determined by slide agglutination using pathogenic
Case Reports
CASE 1:
A male infant was born at 37 weeks and 6 days of gestation by spontaneous vaginal delivery, with a birth weight of 2214 g. The pregnancy and perinatal course were unremarkable. The infant developed fever and poor feeding on day of life (DOL) 15. He was admitted in a state of shock with respiratory distress, poor peripheral perfusion, and coagulopathy. Laboratory findings (Table 1) were consistent with acute liver failure (hepatic-based coagulopathy defined as a prothrombin time exceeding 15 s or an international normalized ratio above 1.5, biochemical evidence of acute liver injury, and no known evidence of chronic liver disease) [6]. Based on the presence of systemic inflammatory response and multiorgan dysfunction, the infant was diagnosed with septic shock. Intensive care management was initiated, including broad-spectrum antimicrobial therapy, mechanical ventilation, vasoactive support, plasma exchange, and continuous renal replacement therapy. Blood cultures obtained on admission yielded E. coli. Urine culture findings were negative, and cerebrospinal fluid examination was deferred due to severe coagulopathy. Despite gradual stabilization of systemic inflammation, hepatic function did not recover, and the patient was transferred for liver transplantation on DOL 26. Metabolic disease screening revealed no specific inborn errors of metabolism. The clinical course is shown in Figure 1.
Microbiological analysis identified an untypeable O serogroup, H2 flagellar antigen, sequence type 348, and phylogenetic group B1. The isolate lacked the K1 and K5 capsule genes but harbored the
CASE 2:
A male infant was born at 38 weeks and 6 days of gestation by spontaneous vaginal delivery, with a birth weight of 2782 g. No abnormalities were detected on newborn metabolic screening. The infant developed fever and feeding difficulty on DOL 7. He rapidly progressed to shock with respiratory and circulatory failure. Laboratory findings (Table 1) were consistent with acute liver failure and disseminated intravascular coagulation [6]. Sepsis was suspected; intensive treatment was initiated, including broad-spectrum antibiotics, mechanical ventilation, vasoactive agents, plasma exchange, and continuous renal replacement therapy. Blood cultures obtained on admission showed E. coli, whereas cerebrospinal fluid and urine cultures yielded negative findings. Although systemic inflammation improved, hepatic failure persisted, and the patient was transferred for liver transplantation on DOL 16. The clinical course is shown in Figure 2.
Microbiological analysis revealed the O25: H4 serotype, sequence type 131, and phylogenetic group B2. The isolate carried the
Discussion
This case series demonstrates that non-K1
The liver plays a central role in host defense via complement synthesis, bacterial clearance by the reticuloendothelial system, and immune surveillance [4,5]. Acute liver failure results in quantitative and qualitative complement deficiencies, which may predispose patients to bloodstream infections. In this context, the
Although complement levels were not directly measured in our patients, both exhibited severe liver dysfunction requiring transplantation, which strongly suggested humoral innate immunity impairment. The identification of
Conclusions
Liver failure in infants may predispose to bacteremia caused by non-K1
Data Availability
The data that support the findings of this study are available on request from the corresponding author. These data are not publicly available due to privacy or ethical restrictions.
Figures
Figure 1. Clinical course of case 1 with acute liver failure complicated by Escherichia coli bacteremia. ABx – antibiotics; FFP – fresh frozen plasma; PC – platelet concentrate; PE – plasma exchange; PLT – platelets; PT – prothrombin time.
Figure 2. Clinical course of case 2 with acute liver failure complicated by Escherichia coli bacteremia. ABx – antibiotics; FFP – fresh frozen plasma; PC – platelet concentrate; PE – plasma exchange; PLT – platelets; PT – prothrombin time. References
1. Croxen MA, Finlay BB: Nat Rev Microbiol, 2010; 8; 26-30
2. Basmaci R, Bonacorsi S, Bidet P: Clin Infect Dis, 2015; 61; 779-86
3. Biran D, Sura T, Otto A: Infect Immun, 2021; 89; e0031621
4. Bartoletti M, Giannella M, Lewis RE, Viale P, Bloodstream infections in patients with liver cirrhosis: Virulence, 2016; 7; 309-19
5. Rimola A, Soto R, Bory F, Arroyo V, Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infection and prognosis: Hepatology, 1984; 4; 53-58
6. Squires RH, Shneider BL, Bucuvalas J, Acute liver failure in children: The first 348 patients in the pediatric acute liver failure study group: J Pediatr, 2006; 148; 652-58
Figures
Figure 1. Clinical course of case 1 with acute liver failure complicated by Escherichia coli bacteremia. ABx – antibiotics; FFP – fresh frozen plasma; PC – platelet concentrate; PE – plasma exchange; PLT – platelets; PT – prothrombin time.
Figure 2. Clinical course of case 2 with acute liver failure complicated by Escherichia coli bacteremia. ABx – antibiotics; FFP – fresh frozen plasma; PC – platelet concentrate; PE – plasma exchange; PLT – platelets; PT – prothrombin time. In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949976
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950290
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950607
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950985
Most Viewed Current Articles
07 Dec 2021 : Case report
17,691,734
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
164,491
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
113,090
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
59,175
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133







